Cumbo Alexander — SEC Form 4 filings

SEC reporting owner CIK 1685994. 18 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2024-02-16 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Solid Biosciences Inc. (SLDB)President and CEO, Director106 legs · 179,102 sh · $1,091,09920
Verve Therapeutics, Inc. (VERV)Director34
Climb Bio, Inc. (CLYM)Director33
Vor Biopharma Inc. (VOR)Director22

Form 4 filings — Cumbo Alexander

FiledFormIssuerReported transactionsSource
2026-06-124Vor Biopharma Inc. (VOR)Grant/award (A): 56,345 (derivative) @ $0EDGAR
2026-06-084Climb Bio, Inc. (CLYM)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2026-04-214Solid Biosciences Inc. (SLDB)Grant/award (A): 169,401 (derivative) @ $0EDGAR
2026-02-184Solid Biosciences Inc. (SLDB)Option exercise (M): 30,031 · Sale (S): 16,644 @ $5.82 · Option exercise (M): 30,031 (derivative) @ $0EDGAR
2026-02-064Solid Biosciences Inc. (SLDB)Sale (S): 48,913 @ $6.44EDGAR
2026-02-024Solid Biosciences Inc. (SLDB)Option exercise (M): 169,401 · Option exercise (M): 100,400 · Sale (S): 80,258 @ $6.44 · Option exercise (M): 169,401 (derivative) @ $0 · Grant/award (A): 509,850 (derivative) @ $0 · Grant/award (A): 254,900 (derivative) @ $0 · +1 moreEDGAR
2025-12-044Solid Biosciences Inc. (SLDB)Option exercise (M): 28,612 · Sale (S): 10,808 @ $5.11 · Option exercise (M): 28,612 (derivative) @ $0EDGAR
2025-08-184Solid Biosciences Inc. (SLDB)Grant/award (A): 337,500 (derivative) @ $0 · Grant/award (A): 168,750 (derivative) @ $0EDGAR
2025-07-284Verve Therapeutics, Inc. (VERV)Disposition to issuer (D): 136,139 (derivative) · Disposition to issuer (D): 42,200 (derivative)EDGAR
2025-07-184Vor Biopharma Inc. (VOR)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2025-06-064Verve Therapeutics, Inc. (VERV)Grant/award (A): 42,200 (derivative) @ $0EDGAR
2025-06-054Climb Bio, Inc. (CLYM)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-04-014Climb Bio, Inc. (CLYM)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2025-02-184Solid Biosciences Inc. (SLDB)Option exercise (M): 30,031 · Sale (S): 11,365 @ $3.96 · Option exercise (M): 30,031 (derivative) @ $0EDGAR
2025-02-114Solid Biosciences Inc. (SLDB)Grant/award (A): 401,600 (derivative) @ $0EDGAR
2024-12-044Solid Biosciences Inc. (SLDB)Option exercise (M): 28,612 · Sale (S): 11,114 @ $5.60 · Option exercise (M): 28,612 (derivative) @ $0EDGAR
2024-06-284Verve Therapeutics, Inc. (VERV)Grant/award (A): 136,139 (derivative) @ $0EDGAR
2024-02-164Solid Biosciences Inc. (SLDB)Grant/award (A): 240,250 (derivative) @ $0 · Grant/award (A): 120,125 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1685994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →